Cannabinoids, the active components of Cannabis sativa (marijuana). and the
ir endogenous counterparts exert their effects by binding to specific G(i/o
)-protein-coupled receptors that modulate adenylyl cyclase, ion channels an
d extracellular signal-regulated kinases. Recent research has shown that th
e CB1 cannabinoid receptor is coupled to the generation of the lipid second
messenger ceramide via two different pathways: sphingomyelin hydrolysis, a
nd ceramide synthesis de nova, Ceramide in turn mediates cannabinoid-induce
d apoptosis, as shown by in vitro and in vivo studies. These findings provi
de a new perspective on how cannabinoids act, and raise exciting physiologi
cal and therapeutic questions.